Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.
Rezaee A, Rahmanian P, Nemati A, Sohrabifard F, Karimi F, Elahinia A, Ranjbarpazuki A, Lashkarbolouki R, Dezfulian S, Zandieh MA, Salimimoghadam S, Nabavi N, Rashidi M, Taheriazam A, Hashemi M, Hushmandi K. Rezaee A, et al. Among authors: salimimoghadam s. Heliyon. 2024 Apr 18;10(9):e29871. doi: 10.1016/j.heliyon.2024.e29871. eCollection 2024 May 15. Heliyon. 2024. PMID: 38707342 Free PMC article. Review.
Shedding light on function of long non-coding RNAs (lncRNAs) in glioblastoma.
Hashemi M, Mousavian Roshanzamir S, Orouei S, Daneii P, Raesi R, Zokaee H, Bikarannejad P, Salmani K, Khorrami R, Deldar Abad Paskeh M, Salimimoghadam S, Rashidi M, Hushmandi K, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: salimimoghadam s. Noncoding RNA Res. 2024 Feb 6;9(2):508-522. doi: 10.1016/j.ncrna.2024.02.002. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38511060 Free PMC article. Review.
Curcumin in treatment of hematological cancers: Promises and challenges.
Entezari M, Tayari A, Paskeh MDA, Kheirabad SK, Naeemi S, Taheriazam A, Dehghani H, Salimimoghadam S, Hashemi M, Mirzaei S, Samarghandian S. Entezari M, et al. Among authors: salimimoghadam s. J Tradit Complement Med. 2024 Jan 5;14(2):121-134. doi: 10.1016/j.jtcme.2023.10.004. eCollection 2024 Mar. J Tradit Complement Med. 2024. PMID: 38481552 Free PMC article. Review.
Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response.
Hashemi M, Daneii P, Zandieh MA, Raesi R, Zahmatkesh N, Bayat M, Abuelrub A, Khazaei Koohpar Z, Aref AR, Zarrabi A, Rashidi M, Salimimoghadam S, Entezari M, Taheriazam A, Khorrami R. Hashemi M, et al. Among authors: salimimoghadam s. Noncoding RNA Res. 2023 Nov 13;9(1):84-104. doi: 10.1016/j.ncrna.2023.11.005. eCollection 2024 Mar. Noncoding RNA Res. 2023. PMID: 38075202 Free PMC article. Review.
miRNAs as short non-coding RNAs in regulating doxorubicin resistance.
Mirzaei S, Paskeh MDA, Moghadam FA, Entezari M, Koohpar ZK, Hejazi ES, Rezaei S, Kakavand A, Aboutalebi M, Zandieh MA, Rajabi R, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S. Mirzaei S, et al. Among authors: salimimoghadam s. J Cell Commun Signal. 2023 Dec;17(4):1181-1202. doi: 10.1007/s12079-023-00789-0. Epub 2023 Nov 29. J Cell Commun Signal. 2023. PMID: 38019354 Free PMC article. Review.
Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.
Bagheri M, Zandieh MA, Daryab M, Samaei SS, Gholami S, Rahmanian P, Dezfulian S, Eary M, Rezaee A, Rajabi R, Khorrami R, Salimimoghadam S, Hu P, Rashidi M, Ardakan AK, Ertas YN, Hushmandi K. Bagheri M, et al. Among authors: salimimoghadam s. Transl Oncol. 2024 Jan;39:101838. doi: 10.1016/j.tranon.2023.101838. Epub 2023 Nov 27. Transl Oncol. 2024. PMID: 38016356 Free PMC article. Review.
Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.
Hashemi M, Aparviz R, Beickzade M, Paskeh MDA, Kheirabad SK, Koohpar ZK, Moravej A, Dehghani H, Saebfar H, Zandieh MA, Salimimoghadam S, Rashidi M, Taheriazam A, Entezari M, Samarghandian S. Hashemi M, et al. Among authors: salimimoghadam s. Biomed Pharmacother. 2023 Dec 31;169:115927. doi: 10.1016/j.biopha.2023.115927. Epub 2023 Nov 24. Biomed Pharmacother. 2023. PMID: 38006616 Free article. Review.
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Bahonar A, Nakhaee Z, Entezari M, Beig Goharrizi MAS, Salimimoghadam S, Ren J, Nabavi N, Rashidi M, Dehkhoda F, Taheriazam A, Tan SC, Hushmandi K. Sadrkhanloo M, et al. Among authors: salimimoghadam s. Pathol Res Pract. 2023 Nov;251:154902. doi: 10.1016/j.prp.2023.154902. Epub 2023 Oct 21. Pathol Res Pract. 2023. PMID: 37922723 Review.
Graphene oxide nanoarchitectures in cancer therapy: Drug and gene delivery, phototherapy, immunotherapy, and vaccine development.
Sadeghi MS, Sangrizeh FH, Jahani N, Abedin MS, Chaleshgari S, Ardakan AK, Baeelashaki R, Ranjbarpazuki G, Rahmanian P, Zandieh MA, Nabavi N, Aref AR, Salimimoghadam S, Rashidi M, Rezaee A, Hushmandi K. Sadeghi MS, et al. Among authors: salimimoghadam s. Environ Res. 2023 Nov 15;237(Pt 2):117027. doi: 10.1016/j.envres.2023.117027. Epub 2023 Sep 1. Environ Res. 2023. PMID: 37659647 Review.
44 results